Categories: All postsCannabis

Buy Plus Products for 75 per cent upside, PI says

California-based edibles manufacturer Plus Products (Plus Products Stock Quote, Chart CSE:PLUS) could add another $12 to $15 million in revenue through the purchase of its cannabis oil supplier Emerald Bay Wellness, says PI Financial analyst Jason Zandberg, who in a corporate update to clients on Thursday reiterated his “Buy” rating and C$7.75 target for PLUS.

Plus Products on Thursday announced it had acquired an option to purchase Emerald Bay, which currently provides Plus with the cannabis oil it uses to make gummies and mints. The deal grants Plus the irrevocable right but not the obligation to purchase Emerald Bay for 1.2 million subordinate voting shares, $250,000 in cash and forgiveness of a $250,000 loan which Plus is to provide Emerald Bay. The payment is subject to performance targets including achieving $28 million in revenue over a two year period. (All figures in US dollars unless noted otherwise.)

Zandberg says that exercising the option would give Plus vertical integration and thus higher gross margins, better quality control and new revenue streams (adding approximately $12 to $15 million in revenue per annum), while if it doesn’t exercise the option, Plus ensures that one of its key suppliers has sufficient funding to continue to supply quality oil for Plus.

“We believe that PLUS Products represents the best way for investors to gain exposure to the fast growing cannabis edibles market in the US. In California, PLUS’ Uplift and Restore gummies are the top two selling edible products and PLUS has recently announced its launch into Nevada. We believe purchasing Emerald Bay will allow PLUS to continue to be among the fastest growing cannabis companies without the concern of obtaining cannabis oil as its sales volumes increase in the future,” says Zandberg.

The analyst thinks Plus will generate fiscal 2019 revenue and EBITDA of $23.1 million and negative $4.5 million, respectively. His C$7.75 target represented a projected return of 74.9 per cent at the time of publication.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: plus
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

2 days ago

Is SNAP a buy right now?

He feels the company made forward progress in its recent quarterly results, but Roth MKM analyst Rohit Kulkarni wants to… [Read More]

2 days ago

Bombardier wins price target raise at Desjardins

Following the company's first quarter results, Desjardins analyst Benoit Poirier has raised his price target on Bombardier (Bombardier Stock Quote,… [Read More]

2 days ago

Rogers is an undervalued stock, RBC says

With the integration of Shaw Communications underway, RBC analyst Drew McReynolds says Rogers Communications (Rogers Communications Stock Quote, Chart, News,… [Read More]

3 days ago

Tornado Global Hydrovacs is still a double, Beacon says

Following fourth quarter results he describes as "stronger than expected", Beacon Securities analyst Russell Stanley has raised his price target… [Read More]

3 days ago

Sell your Molson Coors stock, Citi says

Ahead if its first quarter results, Citi analyst Filippo Falorni says there is not much to like about Molson Coors… [Read More]

4 days ago